olopatadine 2 MG/ML Ophthalmic Solution [Pataday]
- RxCUI
- 1111345
- RxNorm name
- olopatadine 2 MG/ML Ophthalmic Solution [Pataday]
- Display name
- PATADAY (Ophthalmic)
- Full name
- olopatadine 2 MG/ML Ophthalmic Solution [Pataday]
- Term type
- SBD
- Status
- Active
- Strength
- 0.2%
- Dose form
- Sol
- Route
- Ophthalmic
- Updated
- 2026-11-04 11:28:59
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 072011
- Active start
- 072011
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| olopatadine hydrochloride | 2 MG / 1 ML | olopatadine | olopatadine |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Ophthalmic Solution | 7670 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| olopatadine | 135391 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Pataday 0.2 % Ophthalmic Solution | 1 | NAMES |
| RxNorm Name | olopatadine 2 MG/ML Ophthalmic Solution [Pataday] | 1 | NAMES |
| RxNorm Synonym | 2 | NAMES | |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 1c7d2342-ba1c-4244-9814-d92a05725d4e | 1 | CODES |
| RxCUI | 1111345 | 1 | CODES |
| MMSL_CODE | BD19079 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0065-8150-01 | 0065-8150 | PATADAY ONCE DAILY RELIEF OLOPATADINE HYDROCHLORIDE | Alcon Laboratories, Inc. | NDA021545 |
| 0065-8150-03 | 0065-8150 | PATADAY ONCE DAILY RELIEF OLOPATADINE HYDROCHLORIDE | Alcon Laboratories, Inc. | NDA021545 |
| 0065-8150-04 | 0065-8150 | PATADAY ONCE DAILY RELIEF OLOPATADINE HYDROCHLORIDE | Alcon Laboratories, Inc. | NDA021545 |
| 0065-8150-07 | 0065-8150 | PATADAY ONCE DAILY RELIEF OLOPATADINE HYDROCHLORIDE | Alcon Laboratories, Inc. | NDA021545 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PATADAY ONCE DAILY RELIEF | OLOPATADINE HYDROCHLORIDE | Alcon Laboratories, Inc. | 1c7d2342-ba1c-4244-9814-d92a05725d4e | 2026-01-20 | Warnings | 0065-8150-04 0065-8150-01 0065-8150-07 0065-8150-03 0065-8150 00065815003 00065815007 00065815001 00065815004 1111345 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 1c7d2342-ba1c-4244-9814-d92a05725d4e | Pataday Once Daily 0.2 % Ophthalmic Solution [PSN] · olopatadine 2 MG/ML Ophthalmic Solution [Pataday] [SBD] · Pataday 0.2 % Ophthalmic Solution [SY] · Pataday 2 MG/ML (olopatadine HCl 2.22 MG/ML) Ophthalmic Solution [SY] | 4 | 7 | Drug Facts | 20260120 |
| ee6e2161-789b-4ba0-b234-d4b36fe41c94 | Pataday Once Daily 0.2 % Ophthalmic Solution [PSN] · olopatadine 2 MG/ML Ophthalmic Solution [Pataday] [SBD] · Pataday 0.2 % Ophthalmic Solution [SY] · Pataday 2 MG/ML (olopatadine HCl 2.22 MG/ML) Ophthalmic Solution [SY] | 4 | 1 | 20110105 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 1c7d2342-ba1c-4244-9814-d92a05725d4e | Drug Facts | Alcon Laboratories, Inc. | Alcon Research LLC | 20260120 |
| e1eb5130-e59d-4590-8b04-7b1a6adae5bd | These highlights do not include all the information needed to use PATADAY™ safely and effectively. See full prescribing information for PATADAY™. PATADAY™ (olopatadine hydrochloride ophthalmic solution) 0.2% Initial U.S. Approval: 1996 | Alcon Laboratories, Inc. | 20201217 |
| 10c2d217-8307-4457-bab6-e071e7af90ff | National Council for Prescription Drug Programs | 20120724 | |
| cad510e4-8a94-4704-8c78-69e9daf66a0e | National Council for Prescription Drug Programs | 20120724 | |
| d1018edd-12bf-4031-92aa-d79f620b0b7f | National Council for Prescription Drug Programs | 20120724 | |
| ee6e2161-789b-4ba0-b234-d4b36fe41c94 | Physicians Total Care, Inc. | 20110105 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | R01AC | Antiallergic agents, excl. corticosteroids | ATC1-4 | olopatadine | |
| ATC | S01GX | Other antiallergics | ATC1-4 | olopatadine | |
| FDASPL | N0000175587 | Histamine-1 Receptor Antagonist | EPC | has_epc | olopatadine |
| FDASPL | N0000175519 | Histamine-1 Receptor Inhibitor | EPC | has_epc | olopatadine |
| FDASPL | N0000175630 | Mast Cell Stabilizer | EPC | has_epc | olopatadine |
| FDASPL | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | olopatadine |
| FDASPL | N0000175628 | Decreased Histamine Release | PE | has_pe | olopatadine |
| MEDRT | D000069605 | Olopatadine Hydrochloride | CHEM | has_ingredient | olopatadine |
| MEDRT | D003233 | Conjunctivitis, Allergic | DISEASE | may_treat | olopatadine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | olopatadine |
| MEDRT | N0000000190 | Histamine H1 Receptor Antagonists | MOA | has_moa | olopatadine |
| MEDRT | N0000008657 | Decreased Histamine Activity | PE | has_pe | olopatadine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 2 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | NDA | NDA021545 |
| NAMES | Prescribable Synonym | Pataday Once Daily 0.2 % Ophthalmic Solution |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |